Sign up to see all 5.
Sign up to see all 5.
Sign up to see all 5.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
MS
Morgan Stanley
|
42.9M | 9.65% | −640.0K (−1.5%) | ≤2021 | 0.1% | |
|
Shares held by quarter
Peak holding55.3M (Q4'25)
Change over 8 quarters+1.9M
Share of the company9.650%
|
||||||
|
CI
Capital International Investors
|
35.3M | 7.93% | +268.0K (+0.8%) | 2025 | 0.4% | |
|
Shares held by quarter
Peak holding35.3M (Q2'26)
Change over 8 quarters+35.3M
Share of the company7.930%
|
||||||
28 more super investors behind a free account
See every manager holding Royalty Pharma PLC, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VE
Vanguard Index Funds
|
$251M | 4.5M | 1.00% | 0.26% | June 30, 2026 |
|
VF
Victory Portfolios II
|
$137M | 2.4M | 0.55% | 1.76% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Royalty Pharma PLC and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LG
Legorreta G. Pablo
5%+ holder
13D · 18.7%
|
101.8M | 22.87% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
SA
Severgnini Achille G.
5%+ holder
13D · 4.8%
|
21.4M | 4.80% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...